新宙邦(300037) - 2017 Q1 - 季度财报
CAPCHEMCAPCHEM(SZ:300037)2017-04-19 16:00

Financial Performance - Total revenue for Q1 2017 reached ¥388,513,577.18, an increase of 29.93% compared to ¥299,010,544.24 in the same period last year[7] - Net profit attributable to shareholders was ¥67,694,567.10, up 27.34% from ¥53,158,480.24 year-on-year[7] - Net profit after deducting non-recurring gains and losses was ¥63,060,897.45, reflecting a 23.67% increase from ¥50,992,421.64 in the previous year[7] - Basic earnings per share rose to ¥0.36, a 24.14% increase from ¥0.29 in the same period last year[7] - Operating profit reached 78.20 million yuan, reflecting a year-on-year growth of 22.62%[23] - The company reported a net profit increase, with retained earnings rising to CNY 798,656,741.94 from CNY 730,962,174.84, an increase of 9.3%[45] - The total comprehensive income for Q1 2017 was CNY 69,834,286.09, compared to CNY 54,809,852.60 in the prior year, reflecting a strong performance[52] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,955,711,003.45, representing a 5.67% increase from ¥2,797,121,418.75 at the end of the previous year[7] - The total liabilities increased to CNY 670,643,665.60 in Q1 2017 from CNY 588,812,918.37 at the start of the year, marking a rise of 13.9%[44] - The owner's equity totaled CNY 2,285,067,337.85 at the end of Q1 2017, compared to CNY 2,208,308,500.38 at the beginning of the year, indicating an increase of 3.5%[45] Cash Flow - The net cash flow from operating activities was negative at -¥26,530,058.54, a decline of 264.28% compared to ¥16,149,665.46 in the same period last year[7] - Cash inflows from operating activities totaled CNY 376,094,683.45, significantly higher than CNY 263,624,942.06 in the previous period, indicating improved cash generation[58] - The net cash flow from operating activities was -71,430,086.00 CNY, compared to a positive cash flow of 21,624,221.67 CNY in the previous period[61] - The total cash and cash equivalents at the end of the period were 110,779,003.55 CNY, down from 132,356,332.81 CNY in the previous period[64] Shareholder Information - The top 10 shareholders hold a total of 92,000,000 shares, with the largest shareholder, Qin Jiusan, owning 15.09% (28,549,968 shares) and having 21,412,476 shares pledged[15] - The number of restricted shares at the beginning of the period was 75,183,412, with 4,156,472 shares released and 5,196,800 shares added, resulting in a total of 76,223,740 restricted shares at the end of the period[18] - The company has a significant number of shares under lock-up due to executive restrictions, with Qin Jiusan having 21,412,476 shares locked[17] - The total number of shares pledged by major shareholders amounts to 1,060,000 shares[15] Investment and Projects - The total investment commitment for the aluminum electrolytic capacitor project is CNY 9,732.6 million, with a cumulative investment of CNY 9,832.0 million, achieving 101.02% of the planned investment[34] - The lithium-ion battery chemical project has a total investment commitment of CNY 6,200 million, with a cumulative investment of CNY 6,612.9 million, achieving 101.47% of the planned investment[34] - The company has allocated RMB 30 million of raised funds for the construction of new electronic chemical projects in Huizhou and Nantong, with specific investments of RMB 68 million and RMB 215 million for different sub-projects[35] Market and Operational Risks - The company faces risks related to safety and environmental protection, which may increase operational costs due to stricter regulations[10] - The fluctuation in raw material prices, particularly lithium hexafluorophosphate, could impact product pricing and profitability[11] - The competitive landscape in the lithium battery electrolyte market is intensifying, necessitating strategic adjustments to maintain market share[12] Research and Development - The company obtained 9 domestic and international invention patent authorizations during the reporting period, with a total of 220 pending applications[24] - The company has ongoing investments in new product development and technology, as indicated by the increase in development expenditures to CNY 11,084,132.34 from CNY 8,001,424.88, a rise of 38.8%[45] Compliance and Governance - The company has not reported any non-compliance with external guarantees during the reporting period[38] - There were no significant changes in the feasibility of projects during the reporting period[35] - The company has not utilized any idle raised funds for temporary working capital[36]

CAPCHEM-新宙邦(300037) - 2017 Q1 - 季度财报 - Reportify